COMpassion for Psychiatric Disorders And Self-Stigma
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jan 24, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The COMpassion for Psychiatric Disorders And Self-Stigma trial is studying how a special type of therapy called Compassion Focused Therapy (CFT) can help people with mental health conditions like bipolar disorder, schizophrenia, depression, borderline personality disorder, and autism spectrum disorder. Many individuals with these conditions face negative attitudes from society, which can lead to feelings of shame and self-stigma—where they start to believe the negative things others think about them. This study aims to see if participating in group CFT can reduce these feelings of self-stigma and improve their overall well-being compared to standard treatment options.
To be part of this study, participants need to be at least 18 years old, diagnosed with a chronic psychiatric disorder, and have moderate to high self-stigma. They should not be currently in a crisis or participating in other experimental treatments. If eligible, participants will join group therapy sessions designed to foster self-compassion and reduce feelings of shame, which can lead to better coping skills and a more fulfilling recovery. This trial is currently recruiting participants, and it provides a supportive environment for individuals seeking to improve their mental health and social integration.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient ≥18 years of age
- • 2. Patient informed of the results of the preliminary medical examination
- • 3. Patient affiliated to a social health insurance plan (beneficiary or beneficiary's family)
- • 4. Patient with one or several diagnoses of chronic psychiatric disorder (schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depression, borderline personality disorder) or a neurodevelopmental disorder (autism spectrum disorder) treated as an outpatient or in a day hospital
- • 5. CGI-Severity score\<6 assessed by the psychiatrist (Berk et al., 2008) ISMI score indicating moderate to high self-stigma (\>2.5; Lysaker et al., 2007)
- Exclusion criteria:
- • 6. Patient in an exclusion period determined by a previous or ongoing study
- • 7. Patient participating in an interventional study involving psychotherapy or an experimental drug
- • 8. Patient in acute episode of their disorder according to the CGI Severity score
- • 9. Patient in a medical emergency or immediate life-threatening situation
- • 10. Patients with an intellectual disability (IQ\<70) estimated via the fNART (Mackinnon \& Mulligan, 2005)
- • 12. Legal issues: care under constraint or patient deprived of freedom because of a judicial measure 13. Patient who does not speak and read French sufficiently
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Strasbourg, , France
Bordeaux, , France
Clermont Ferrand, , France
Laxou, , France
Montpellier, , France
Reims, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials